Some studies also found that the expression of SLC2A1 in breast cancer (Finak et al., 2008), esophageal cancer (Kim et al., 2010), and leukemia (Haferlach et al., 2010) was lower than that in normal samples (Figure 2A). Here, SLC2A1 is linked to breast cancer.